There has never been a reason given for the switch from anatabine to isomyosmine, but in a comparative study isomyosmine had the greatest impact on the reduction of MOA-a and MOA-b.
My personal feeling was that they were just fleeing the negativity surrounding anatabine as well as the financial crisis of the share issuance to pay for studies!